December 17, 2015: Draft EMA Pain Guideline Cites Multiple IMMPACT/ACTTION Articles

The European Medicines Agency (EMA) has released an updated draft "Guideline on the Clinical Development of Medicinal Products Intended for the Treatment of Pain." The draft guideline references multiple IMMPACT/ACTTION articles that have presented recommended considerations for the design, analysis, and interpretation of adult and pediatric clinical trials of pain treatments. This important attention to ACTTION's efforts provides independent recognition of its contributions to advancing the development of improved pain treatments. The draft guideline is available here.